Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

The Lancet Neurology

Volumn 15, Issue 9, 2016, Pages 913-924

  Feigin, Valery L ^a   Roth, Gregory A ^b   Naghavi, Mohsen ^b   Parmar, Priya ^a   Krishnamurthi, Rita ^a   Chugh, Sumeet ^b   Mensah, George A ^c   Norrving, Bo ^d   Shiue, Ivy ^e,f   Ng, Marie ^b   Estep, Kara ^b   Cercy, Kelly ^b   Murray, Christopher J L ^b   Forouzanfar, Mohammad H ^b  

^a AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d LUND UNIVERSITY   (Sweden)

^e NORTHUMBRIA UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TOBACCO SMOKE;

AIR POLLUTION; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; DIET; ENVIRONMENTAL FACTOR; HUMAN; INTERVENTION STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; FEMALE; GLOBAL DISEASE BURDEN; GLOBAL HEALTH; MALE; STATISTICS AND NUMERICAL DATA; STROKE; TRENDS;

FEMALE; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HUMANS; MALE; RISK FACTORS; STROKE;

EID: 84992202449     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(16)30073-4     Document Type: Article

References (44)

1. 1 GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 2287–2323.
2. 2 Murray, CJL, Lopez, AD, Measuring the global burden of disease. N Engl J Med 369 (2013), 448–457.
3. 3 Feigin, VL, Krishnamurthi, RV, Parmar, P, et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: the GBD 2013 Study. Neuroepidemiology 45 (2015), 161–176.
4. 4 Roth, GA, Johnson, CO, Nguyen, G, et al. Methods for estimating the global burden of cerebrovascular diseases. Neuroepidemiology 45 (2015), 146–151.
5. 5 Truelsen, T, Krarup, LH, Iversen, HK, et al. Causes of death data in the Global Burden of Disease estimates for ischemic and hemorrhagic stroke. Neuroepidemiology 45 (2015), 152–160.
6. 6 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
7. 7 GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386 (2015), 2145–2191.
8. 8 SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
9. 9 Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
10. 10 Ng, M, Fleming, T, Robinson, M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
11. 11 Fowkes, FGR, Rudan, D, Rudan, I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382 (2013), 1329–1340.
12. 12 Feigin, VL, Forouzanfar, MH, Krishnamurthi, R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383 (2014), 245–254.
13. 13 WHO. Global health risk: mortality and burden of disease attributable to selected major risks, 2009, World Health Organization, Geneva.
14. 14 Malik, VS, Willett, WC, Hu, FB, Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 9 (2013), 13–27.
15. 15 Cesare, MD, Bennett, JE, Best, N, Ezzati, M, Stevens, GA, Danaei, G, The contributions of risk factor trends to cardiometabolic mortality decline in 26 industrialized countries. Int J Epidemiol 42 (2013), 838–848.
16. 16 Yusuf, S, Rangarajan, S, Teo, K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med 371 (2014), 818–827.
17. 17 WHO. The world health report 2002—reducing risks, promoting healthy life, 2002, World Health Organisation, Geneva http://www.who.int/whr/2002 (accessed Jan 16, 2016).
18. 18 O'Donnell, MJ, Xavier, D, Liu, L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376 (2010), 112–123.
19. 19 Hu, G, Tuomilehto, J, Silventoinen, K, Sarti, C, Männistö, S, Jousilahti, P, Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med 167 (2007), 1420–1427.
20. 20 Kontogianni, MD, Panagiotakos, DB, Dietary patterns and stroke: a systematic review and re-meta-analysis. Maturitas 79 (2014), 41–47.
21. 21 He, FJ, Li, J, MacGregor, GA, Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ, 346, 2013, f1325.
22. 22 Lock, K, Pomerleau, J, Causer, L, Altmann, DR, McKee, M, The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bull World Health Organ 83 (2005), 100–108.
23. 23 Pierce, JP, Messer, K, White, MM, Cowling, DW, Thomas, DP, Prevalence of heavy smoking in California and the United States, 1965–2007. JAMA 305 (2011), 1106–1112.
24. 24 Gallus, S, Lugo, A, La Vecchia, C, et al. Pricing policies and control of tobacco in Europe (PPACTE) project: cross-national comparison of smoking prevalence in 18 European countries. Eur J Cancer Prev 23 (2014), 177–185.
25. 25 Liu, Y, Gao, J, Shou, J, et al. The prevalence of cigarette smoking among rural-to-urban migrants in China: a systematic review and meta-analysis. Subst Use Misuse 51 (2016), 1–10.
26. 26 Chen, Z, Peto, R, Zhou, M, et al. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet 386 (2015), 1447–1456.
27. 27 Woodward, M, Martiniuk, A, Ying Lee, CM, et al. Elevated total cholesterol: Its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region. Eur J Cardiovasc Prev Rehabil 15 (2008), 397–401.
28. 28 Barker-Collo, S, Bennett, DA, Krishnamurthi, RV, et al. Sex differences in stroke incidence, prevalence, mortality and disability-adjusted life years: results from the Global Burden of Disease Study 2013. Neuroepidemiology 45 (2015), 203–214.
29. 29 Shah, ASV, Lee, KK, McAllister, DA, et al. Short term exposure to air pollution and stroke: systematic review and meta-analysis. BMJ, 350, 2015, h1295.
30. 30 Brauer, M, Freedman, G, Frostad, J, et al. Ambient air pollution exposure estimation for the Global Burden of Disease 2013. Environ Sci Technol 50 (2016), 79–88.
31. 31 Ostro, B, Hu, J, Goldberg, D, et al. Associations of mortality with long-term exposures to fine and ultrafine particles, species and sources: results from the California Teachers Study Cohort. Environ Health Perspect 123 (2015), 549–556.
32. 32 Navas-Acien, A, Guallar, E, Silbergeld, EK, Rothenberg, SJ, Lead exposure and cardiovascular disease—a systematic review. Environ Health Perspect 115 (2007), 472–482.
33. 33 Kengne, AP, Anderson, CS, The neglected burden of stroke in Sub-Saharan Africa. Int J Stroke 1 (2006), 180–190.
34. 34 Moosa, MR, Van Der Walt, I, Naicker, S, Meyers, AM, Important causes of chronic kidney disease in South Africa. S Afr Med J, 105, 2015, 2681.
35. 35 Ding, EL, Malik, VS, Convergence of obesity and high glycemic diet on compounding diabetes and cardiovascular risks in modernizing China: an emerging public health dilemma. Global Health, 4, 2008, 4.
36. 36 Zaridze, D, Brennan, P, Boreham, J, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48 557 adult deaths. Lancet 373 (2009), 2201–2214.
37. 37 Pomerleau, J, Lock, K, McKee, M, Interventions designed to increase adult fruit and vegetable intake can be effective: a systematic review of the literature. J Nutr 135 (2005), 2486–2495.
38. 38 Tikk, K, Sookthai, D, Monni, S, et al. Primary preventive potential for stroke by avoidance of major lifestyle risk factors: the European Prospective Investigation Into Cancer and Nutrition-Heidelberg cohort. Stroke 45 (2014), 2041–2046.
39. 39 Norrving, B, Davis, SM, Feigin, VL, Mensah, GA, Sacco, RL, Varghese, C, Stroke prevention worldwide—what could make it work. Neuroepidemiology 45 (2015), 215–220.
40. 40 Gaziano, TA, Opie, LH, Weinstein, MC, Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368 (2006), 679–686.
41. 41 Feigin, VL, Krishnamurthi, R, Bhattacharjee, R, et al. New strategy to reduce the global burden of stroke. Stroke 46 (2015), 1740–1747.
42. 42 Morgan, J, The power of the App: can mobile-technology save lives?. Lancet Neurol, 15, 2015, 668.
43. 43 WHO. Global status report on noncommunicable diseases 2010. Description of the global burden of NCDs, their risk factors and determinants, 2011, World Health Organization, Geneva.
44. 44 Collins, FS, Varmus, H, A new initiative on precision medicine. N Engl J Med 372 (2015), 793–795.